phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

A new analysis from The Moran Company found nearly one in five hospitals marks up medicine prices 700 percent or more. With this 700 percent markup, a $150 medicine purchased by a hospital could cost patients up to $1,050.

The study, which was commissioned by PhRMA and looked at total costs and charges for all medicines from 3,792 hospitals using Centers for Medicare and Medicaid Services (CMS) data, also found:

  • Hospitals marked up the price of medicines, on average, nearly 500 percent, a number that mirrors a previous Moran analysis of 20 medicines

  • Eight percent of the hospitals included in the study (320 total) marked up some medicine prices more than 1,000 percent

For hospitals, higher charges are associated with greater profitability. These markups lead to higher costs for everyone — patients, employers and payers. For one, they often lead to higher reimbursement by health plans; more than half of commercial payers reimburse hospital outpatient departments as a percent of billed charges. Additionally, uninsured patients can face the full charge.

It’s also important to note that nearly 50 percent of Medicare acute care hospitals in the United States participate in the 340B drug pricing program, and the average markup at 340B hospitals is likely much higher. This is because medicines acquired by 340B hospitals are purchased, on average, at a 50 percent discount. Consequently, independent economists have called attention to the role of 340B hospitals in driving up health care costs across the country.

PDFtoJPG.me-1

New “Let’s Talk About Cost” campaign ads, launched in conjunction with the study, will be featured in print, radio, digital and social channels in Washington, D.C., and select states. The advertisements highlight how hospital markups can lead to higher costs for patients.

Holly Campbell

Holly Campbell is former deputy vice president of public affairs at PhRMA focusing on the cost and value of medicines.

Holly Campbell

Author Twitter

Author LinkedIn

As football season kicks off, hospitals keep scoring on 340B

September 9, 2026

ICYMI: Hospital consolidation is driving up health care costs

August 27, 2026

It's time to modernize 340B: The case for a rebate model

August 19, 2026

ICYMI: Fox business hosts call 340B a ‘Rotten System’ and ‘Cash Cow’ for hospitals

July 23, 2026

New study finds some hospitals mark up medicine prices at least 700 percent

Drug Cost

340B

Hospitals

Lets Talk About Cost

New study finds some hospitals mark up medicine prices at least 700 percent

September 5, 2018

New study finds some hospitals mark up medicine prices at least 700 percent

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list